Is Nurix Therapeutics, Inc. (NRIX) a Buy, Sell, or Hold?
NASDAQ : NRIX
Nurix Therapeutics, Inc. — Competitors
$23.21 USD
-$0.37 (-1.57%)
- Volume
- 751.72K
- Average Volume
- 2.03M
- Market Capitalization
- $2.41B
- P/E Ratio
- -6.73
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $25.09
- Year Low
- $8.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.34
NRIX vs. The Competition
| Properties | NRIX | BBOT | EYPT | FTRE |
|---|---|---|---|---|
| Market Cap | $2.41B | $648.07M | $1.03B | $1.82B |
| Shares Outstanding | $103.78M | $80.11M | $83.84M | $95.1M |
| P/E Ratio | -6.73 | -1.42 | -3.5 | -20.61 |
| EPS | -3.07 | -4.95 | -3.16 | -0.9 |
| Day Low | 23.08 | 8.01 | 12.04 | 18.21 |
| Day High | 23.68 | 8.74 | 12.73 | 19.38 |
| Year Low | 8.195 | 7 | 9.4 | 5.82 |
| Year High | 25.085 | 14.87 | 19.11 | 21.39 |
| Average Price 50 | 20.389 | 8.2145 | 13.1352 | 16.9338 |
| Average Price 200 | 17.08995 | 10.1305 | 14.09345 | 13.6389 |
| Volume | 751.72K | 356.2K | 1.71M | 1.86M |
| Average Volume | - | - | - | - |